Metastatic Pancreatic Cancer Global Clinical Trials Review, H1, 2012
Metastatic Pancreatic Cancer Global Clinical Trials Review, H1, 2012
Summary
GlobalData's clinical trial report, “Metastatic Pancreatic Cancer Global Clinical Trials Review, H1, 2012" provides data on the Metastatic Pancreatic Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metastatic Pancreatic Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Metastatic Pancreatic Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
Summary
GlobalData's clinical trial report, “Metastatic Pancreatic Cancer Global Clinical Trials Review, H1, 2012" provides data on the Metastatic Pancreatic Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metastatic Pancreatic Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Metastatic Pancreatic Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Contents
IntroductionMetastatic Pancreatic Cancer
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Metastatic Pancreatic Cancer
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Metastatic Pancreatic Cancer Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Eli Lilly and Company
Clinical Trial Overview of Eli Lilly and Company
Taiho Pharmaceutical Co., Ltd.
Clinical Trial Overview of Taiho Pharmaceutical Co., Ltd.
Amgen Inc.
Clinical Trial Overview of Amgen Inc.
F. Hoffmann-La Roche Ltd.
Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
Novartis AG
Clinical Trial Overview of Novartis AG
OSI Pharmaceuticals, Inc.
Clinical Trial Overview of OSI Pharmaceuticals, Inc.
Chugai Pharmaceutical Co., Ltd.
Clinical Trial Overview of Chugai Pharmaceutical Co., Ltd.
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
Rexahn Pharmaceuticals, Inc.
Clinical Trial Overview of Rexahn Pharmaceuticals, Inc.
Clovis Oncology, Inc.
Clinical Trial Overview of Clovis Oncology, Inc.
Celgene Corporation
Clinical Trial Overview of Celgene Corporation
Aduro BioTech
Clinical Trial Overview of Aduro BioTech
Exelixis, Inc.
Clinical Trial Overview of Exelixis, Inc.
PDL BioPharma, Inc.
Clinical Trial Overview of PDL BioPharma, Inc.
Astellas Pharma Inc.
Clinical Trial Overview of Astellas Pharma Inc.
ImClone LLC
Clinical Trial Overview of ImClone LLC
BioSante Pharmaceuticals, Inc.
Clinical Trial Overview of BioSante Pharmaceuticals, Inc.
MediGene AG
Clinical Trial Overview of MediGene AG
FibroGen, Inc.
Clinical Trial Overview of FibroGen, Inc.
Infinity Pharmaceuticals, Inc.
Clinical Trial Overview of Infinity Pharmaceuticals, Inc.
Clinical Trial Overview of Top Universities / Institutes / Hospitals
Dana-Farber Cancer Institute
Clinical Trial Overview of Dana-Farber Cancer Institute
Pancreatic Cancer Research Team
Clinical Trial Overview of Pancreatic Cancer Research Team
UCLA's Jonsson Comprehensive Cancer Center
Clinical Trial Overview of UCLA's Jonsson Comprehensive Cancer Center
University Health Network
Clinical Trial Overview of University Health Network
Fox Chase Cancer Center
Clinical Trial Overview of Fox Chase Cancer Center
Sidney Kimmel Comprehensive Cancer Center
Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center
Centre Val d'Aurelle - Paul Lamarque
Clinical Trial Overview of Centre Val d'Aurelle - Paul Lamarque
Brown University
Clinical Trial Overview of Brown University
European Organization for Research and Treatment of Cancer
Clinical Trial Overview of European Organization for Research and Treatment of Cancer
Academic Medical Centre
Clinical Trial Overview of Academic Medical Centre
The University of Chicago
Clinical Trial Overview of The University of Chicago
The University of Texas M. D. Anderson Cancer Center
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
University Hospital Basel
Clinical Trial Overview of University Hospital Basel
University of Oklahoma
Clinical Trial Overview of University of Oklahoma
University of Medicine and Dentistry New Jersey
Clinical Trial Overview of University of Medicine and Dentistry New Jersey
Massachusetts General Hospital
Clinical Trial Overview of Massachusetts General Hospital
The University of Iowa
Clinical Trial Overview of The University of Iowa
University of Connecticut Health Center
Clinical Trial Overview of University of Connecticut Health Center
University of Ulm
Clinical Trial Overview of University of Ulm
Asan Medical Center
Clinical Trial Overview of Asan Medical Center
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source
LIST OF TABLES
Metastatic Pancreatic Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2012*
Metastatic Pancreatic Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Metastatic Pancreatic Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials, North America, Top Countries, 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials, BRIC Countries, 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials, G7 Countries, 2012*
Metastatic Pancreatic Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials, E7 Countries, 2012*
Metastatic Pancreatic Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
Metastatic Pancreatic Cancer Therapeutics Market, Global, Clinical Trials by Phase, 2012*
Metastatic Pancreatic Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012*
Metastatic Pancreatic Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
Metastatic Pancreatic Cancer Therapeutics Market, Global, Suspended Clinical Trials, 2012*
Metastatic Pancreatic Cancer Therapeutics Market, Global, Terminated Clinical Trials, 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Metastatic Pancreatic Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Taiho Pharmaceutical Co., Ltd., 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by OSI Pharmaceuticals, Inc., 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Chugai Pharmaceutical Co., Ltd., 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Rexahn Pharmaceuticals, Inc., 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Clovis Oncology, Inc., 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Aduro BioTech, 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Exelixis, Inc., 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by PDL BioPharma, Inc., 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by ImClone LLC, 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by BioSante Pharmaceuticals, Inc., 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by MediGene AG, 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by FibroGen, Inc., 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Infinity Pharmaceuticals, Inc., 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pancreatic Cancer Research Team, 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by UCLA's Jonsson Comprehensive Cancer Center, 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Fox Chase Cancer Center, 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Val d'Aurelle - Paul Lamarque, 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Brown University, 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Centre, 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Chicago, 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Basel, 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oklahoma, 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Medicine and Dentistry New Jersey, 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Iowa, 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Connecticut Health Center, 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Ulm, 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2012*
LIST OF FIGURES
Metastatic Pancreatic Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2012*
Metastatic Pancreatic Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Metastatic Pancreatic Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials, BRIC Countries (%), 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials, G7 Countries (%), 2012*
Metastatic Pancreatic Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials, E7 Countries (%), 2012*
Metastatic Pancreatic Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
Metastatic Pancreatic Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2012*
Metastatic Pancreatic Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012*
Metastatic Pancreatic Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Metastatic Pancreatic Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
Metastatic Pancreatic Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
GlobalData Methodology Skip to top